Background: Sofosbuvir and ledipasvir, which have recently been approved for treatment of
chronic hepatitis C virus (HCV) infection, are more efficacious and safer than the old …

Background The COVID-19 pandemic has driven demand for forecasts to guide policy and
planning. Previous research has suggested that combining forecasts from multiple models …

Oral direct‐acting antivirals (DAAs) represent a major advance in hepatitis C virus (HCV)
treatment. Along with recent updates in HCV screening policy and expansions in insurance …

Importance Deaths due to opioid overdose have tripled in the last decade. Efforts to curb
this trend have focused on restricting the prescription opioid supply; however, the near-term …

Breast cancer is the most common non-skin cancer affecting women in the United States,
where every year more than 20 million mammograms are performed. Breast biopsy is …

Computer models in medical diagnosis are being developed to help physicians differentiate
between healthy patients and patients with disease. These models can aid in successful …

Background: Chronic hepatitis C virus (HCV) infection causes a substantial health and
economic burden in the United States. With the availability of direct-acting antiviral agents, …

BACKGROUND: Discriminating malignant breast lesions from benign ones and accurately
predicting the risk of breast cancer for individual patients are crucial to successful clinical …

Background & Aims Direct-acting antivirals (DAAs) are effective in treatment of hepatitis C
virus (HCV) genotype 1 infection, but their cost and value have been debated. We performed a …

Background and Aims Alcohol consumption increased during the COVID‐19 pandemic in
2020 in the United States. We projected the effect of increased alcohol consumption on alcohol…